Development and Validation of an Immunotherapy-Related Prognostic Signature Based on Lymph Node Ratio for Gastric Cancer

Figure 8

The correlation between the risk score and TMB. (a) The difference of TMB between low- and high-risk groups. (b) Pearson correlation analysis between TMB and risk score. (c) The association of TMB and GC patients’ overall survival. (d) The KM curve showing overall survival after combining the risk score with TMB. (e) Mutation profile of GC patients in low-risk group. (f) Mutation profile of GC patients in high-risk group.

(a)

(b)

(c)

(d)

(e)

(f)